HopeStage
Back to all studies
TerminatedNCT01465074

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia

Medication studyAges 18–55Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 2011
Recruitment status
Terminated
Enrollment listed in the registry
20
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT01465074
Official title
Show the full official title

Effects of Acute Nicotine on Long-term Potentiation in the Dorsolateral Prefrontal Cortex of Patients With Schizophrenia and Healthy Controls

Recruitment & locations

Terminated

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Nicotine polacrilex and Regular chewing gum; Dentyne Ice, Wrigely´s Mint Gum.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies